REGNRN

0 analysts have active calls

Thu, Sep 3 · market close

1 long0 exited

calls in the last 30 days · exits close a long — positions are long-only

Backing it now

No analyst holds REGNRN through an active call right now.

Latest call on REGNRN

@harry03994688

Read as: Long REGNRN, Long ALNAYM · Medium confidence

中本麻三@harry03994688
如果你投资biotech 特别注意regeneron和alnylam这两家公司这两家公司以其远超工业水平的FDA approve odds而闻名: 工业水平: ~10% FDA通过. 这两家是> 50%. 超高的成功率不只是技术来保证: 1. 在底层技术的设计上. 2. 在临床试验对药物的设计上. 这两家公司都具备非常深厚的功力, 这不只是运气.
3d agoview on X ↗

tweeted Thu, Sep 3 · counted from Fri, Sep 4 close

view the call →